Peptides with antioxidant and antimicrobial properties

Abstract

One embodiment of the present invention is directed toward methods for inhibiting the oxidation of lipids, proteins, and other compounds. Another embodiment is directed toward methods for treating conditions associated with microbial contamination, colonization, and / or infection.

Description

[0001] This invention was made with government support under Grant No. HL-61612 awarded by the National Institutes of Health. The government has certain rights in the invention.BACKGROUND OF THE INVENTION [0002] The present invention relates generally to methods for reducing or preventing the oxidation of lipids or other molecules, and to methods for inhibiting or reducing microbial proliferation. Specifically, the present invention is directed to compositions and methods for treating oxidative lung injury and other oxidative disorders, and to methods for preventing oxidation of foods, cosmetics and medications. Additionally, the present invention is directed to compositions and methods for treating lung infection and other disorders caused by microbial infection. [0003] The lung is made up of a series of branching conducting airways that terminate in grape-like clusters of delicate gas exchanging airspaces called pulmonary alveoli. Maintenance of alveolar patency at end expiration ...

AI Technical Summary

Benefits of technology

[0014] A number of novel peptides derived from rat lung surfactant proteins SP-A and SP-D possess lipid oxidation inhibiting and / or antimicrobial properties that are similar to the full length molecules. Similarly, novel lipid oxidation suppressant and antimicrobial peptides may be derived from human lung surfactant proteins SP-A and SP-D. When administered by aerosol or by intratracheal instillation, these truncated proteins can be used to decrease lung injury due to hyperoxia, inflammation or infection. When included as ingredients in foods, cosmetics and medications, the truncated proteins can inhibit lipid oxidation or microbial proliferation that produces spoilage, off colors and off flavors. Compared to full length proteins, these peptides are more easily manufactured in quantities that are practical for therapeutic use, or as ingredients in foods, cosmetics and medications. Without being limited by theory, however, it is believed that immunogenicity problems associated with administration of peptides to humans should be limited, since they will comprise specific portions of the native human lung surfactant protein compound proteins.

Problems solved by technology

The pathophysiological consequences of surfactant oxidation in humans and experimental animals exposed to hyperoxia include airspace collapse, reduced lung compliance and impaired gas exchange.

Exposure of surfactant to ambient oxygen and potent environmental oxidants such as ozone can result in peroxidation of unsaturated phospholipids, surfactant inactivation, airspace collapse and impaired gas exchange.

Images